scPharmaceuticals Announces FDA Acceptance of Furoscix New Drug Application Resubmission

BURLINGTON, Mass.--(BUSINESS WIRE)--Jul. 27, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news